DM Clinical Research - Cyfair Clinical Research Center

Houston, Texas 77065-5685

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Respiratory Syncytial Virus, SARS-CoV2, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
• A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults — Running, not enrolling